Understanding how certain proteins regulate cholesterol levels
Post-transcriptional regulation of LDLR
This study is looking at how certain proteins help manage cholesterol levels in the body by affecting the stability of a key messenger molecule, which could lead to new ways to prevent heart disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11052536 on NIH RePORTER |
What this research studies
This research investigates the role of specific RNA binding proteins in controlling the stability of LDL receptor mRNA, which is crucial for maintaining cholesterol levels in the body. By using advanced techniques like CLIP-Seq, the researchers aim to identify how these proteins affect cholesterol homeostasis and their potential protective effects against atherosclerosis. The study will utilize a mouse model that mimics human cholesterol metabolism to explore how these proteins influence cholesterol uptake and conversion to bile acids, which could lead to new therapeutic strategies for cardiovascular disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with elevated LDL cholesterol levels or those at risk for atherosclerotic cardiovascular disease.
Not a fit: Patients with normal cholesterol levels or those not at risk for cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that lower cholesterol levels and reduce the risk of cardiovascular disease.
How similar studies have performed: Previous research has shown success in understanding cholesterol regulation through transcriptional mechanisms, but this approach focusing on post-transcriptional regulation is relatively novel.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Tarling, Elizabeth Joanna — University of California Los Angeles
- Study coordinator: Tarling, Elizabeth Joanna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.